New precision radiation aims to zap prostate tumors while sparing healthy tissue

NCT ID NCT03861676

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests a new way to deliver radiation implants (brachytherapy) for men with localized prostate cancer. By using advanced imaging (PET/CT and ultrasound) to map only the aggressive tumor areas, doctors hope to target the cancer while leaving healthy tissue untouched, potentially reducing side effects. The study enrolls 20 men with low- to intermediate-risk prostate cancer to see if this focused approach can effectively cover the tumor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SKCCC at Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.